Compound Evidence File
#EC-2026-0558
Superdrol
Filed under Oral Tablets. The bureau holds 84 laboratory returns for this compound from 36 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
36 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | X | 1 | 9.3 | 9.3 | 9.3 | 2 Apr 2025 | 2 Apr 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 8.5 | 8.5 | 8.5 | 25 Apr 2025 | 25 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.4 | 8.1 | 8.6 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.2 | 6.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.2 | 7.2 | 9.2 | 24 May 2026 | 24 May 2026 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 5 | 8.2 | 6.5 | 9.6 | 3 Jul 2025 | 21 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 8.0 | 8.0 | 8.0 | 11 Jun 2025 | 11 Jun 2025 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 | 11 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 7.8 | 6.2 | 9.1 | 23 May 2026 | 23 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 7.7 | 7.2 | 8.1 | 21 May 2026 | 21 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 6 | 7.7 | 6.5 | 10.0 | 21 May 2025 | 24 May 2026 |
| Accelerate LabsCASE #VI-2026-0686 | X | 1 | 7.7 | 7.7 | 7.7 | 21 May 2025 | 21 May 2025 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 7.2 | 7.2 | 7.2 | 28 Mar 2025 | 28 Mar 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 3 | 7.0 | 5.6 | 8.6 | 21 May 2025 | 19 Jan 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 6.9 | 6.9 | 6.9 | 14 Jan 2025 | 14 Jan 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 | 9 Jun 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 6.6 | 6.6 | 6.6 | 17 Dec 2024 | 17 Dec 2024 |
| Amino AmigosCASE #VI-2026-0061 | X | 3 | 6.5 | 5.1 | 8.8 | 9 Jun 2025 | 25 May 2026 |
| OupeptideCASE #VI-2026-0435 | X | 4 | 6.2 | 5.6 | 7.5 | 8 Jul 2025 | 19 Jan 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 4 | 6.2 | 3.0 | 9.8 | 28 Mar 2025 | 21 May 2026 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 6.1 | 6.1 | 6.1 | 14 Jan 2025 | 14 Jan 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 5.8 | 4.4 | 7.2 | 2 Jul 2025 | 21 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 5.7 | 5.7 | 5.7 | 28 Mar 2025 | 28 Mar 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 5.5 | 5.5 | 5.5 | 20 Jun 2025 | 20 Jun 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 5.1 | 5.1 | 5.1 | 3 Jun 2025 | 3 Jun 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 2 | 4.4 | 4.0 | 4.8 | 3 Jul 2025 | 24 May 2026 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 3.6 | 3.6 | 3.6 | 2 Apr 2025 | 2 Apr 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 1.1 | 1.1 | 1.1 | 24 Apr 2025 | 24 Apr 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 1.1 | 1.1 | 1.1 | 3 Jun 2025 | 3 Jun 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.1 | 0.1 | 0.1 | 20 Jun 2025 | 20 Jun 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.0 | 0.0 | 0.0 | 6 May 2025 | 6 May 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Jul 2025 | 2 Jul 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 7 May 2025 | 7 May 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 | 25 Apr 2025 |
Open any subject to view the batch-level evidence for Superdrol alone.